Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000508432 | SCV000603440 | pathogenic | not specified | 2016-12-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001794457 | SCV000823044 | pathogenic | Cyclical neutropenia; Neutropenia, severe congenital, 1, autosomal dominant | 2024-12-02 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 126 of the ELANE protein (p.Ser126Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with cyclic neutropenia and severe congenital neutropenia (PMID: 11001877, 14962902, 16079102, 16737875, 18611981, 20582973, 22758217, 23463630). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Ser97Leu. ClinVar contains an entry for this variant (Variation ID: 16745). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on ELANE function (PMID: 16551967, 26567890). For these reasons, this variant has been classified as Pathogenic. |
Mendelics | RCV000990116 | SCV001140921 | pathogenic | Cyclical neutropenia | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000018229 | SCV005328357 | pathogenic | Neutropenia, severe congenital, 1, autosomal dominant | 2024-09-25 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000018229 | SCV000038508 | pathogenic | Neutropenia, severe congenital, 1, autosomal dominant | 2008-01-01 | no assertion criteria provided | literature only | |
Department Of Genetics, |
RCV000018229 | SCV000891498 | pathogenic | Neutropenia, severe congenital, 1, autosomal dominant | 2024-06-12 | no assertion criteria provided | curation | |
Gene |
RCV000990116 | SCV002769685 | not provided | Cyclical neutropenia | no assertion provided | literature only | ||
Prevention |
RCV004752711 | SCV005360939 | pathogenic | ELANE-related disorder | 2024-08-01 | no assertion criteria provided | clinical testing | The ELANE c.377C>T variant is predicted to result in the amino acid substitution p.Ser126Leu. This variant is also described using legacy nomenclature as p.Ser97Leu, has been reported in multiple individuals with congenital neutropenia (Dale et al. 2000. PubMed ID: 11001877; Sera et al. 2005. PubMed ID: 16079102; Newburger et al. 2010. PubMed ID: 20582973; Wali et al. 2012. PubMed ID: 22758217; Gong et al. 2018. PubMed ID: 30386760). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. |